Condition: Solid Tumors · Sponsor: RenovoRx
This study is a multicenter, observational, post-marketing, registry study designed to track the safety and performance of the RenovoCath® device and assess survival outcomes in patients diagnosed with solid tumors who are treated with localized intra-arterial (IA) delivery of therapeutic agents to solid tumors using the RenovoCath® catheter.
This description comes directly from the study's public registry record.
Leesa M Gentry · 650-284-4433 · lgentry@renovorx.com
Nicolette G Keller · 650-284-4433 · nkeller@renovorx.com
Always discuss trial participation with your own doctor first.
| Baptist Health South Florida | Coral Gables, Florida, United States | Recruiting |
| University of Pennsylvania Medical Center | Pittsburgh, Pennsylvania, United States | Recruiting |
| The University of Vermont Medical Center | Burlington, Vermont, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06805461